secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0000950170-25-107345
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex Q2 revenue $13.6M (+7% YoY), net loss narrows to $1.0M; third straight positive adjusted EBITDA
--------------------------------------------------------------------------------

- Revenue $13.6M, up 7% YoY and 14% sequential; retina product revenue $8.0M (+10% YoY).
- Cyclo G6 revenue $3.3M (flat YoY); sold 13,100 probes vs 15,100, and 35 systems vs 28.
- Gross margin 34.5% vs 40.7% a year ago due to higher costs and product mix.
- Operating expenses down 28% YoY to $5.6M; net loss $1.0M ($0.06/sh) vs $2.7M ($0.16/sh).
- Non-GAAP adjusted EBITDA positive $21k, vs loss of $1.7M; cash $6.8M, down $0.4M in quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000095017025107345/0000950170-25-107345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000095017025107345/irix-20250812.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-107345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer